Record-Setting Tarantulas Boast Longest Sex Organs to Avoid Getting Eaten by Females
Meet the Satyrex ferox, S. arabicus, S. somalicus, and S. speciosus. They hail from the Arabian Peninsula and the Horn of Africa and are so different from their closest relatives—on both the morphological and molecular level—that the team created a new genus for them, Satyrex.
'The genus name is a combination of Satyr, a part-man, part-beast entity from Greek mythology known for his exceptionally large genitals, and the Latin rēx, meaning king,' the researchers wrote in a study published last month in the journal ZooKeys.
Like Satyrs, the males of the four new species, as well as a fifth Satyrex species, have the longest known palps of all tarantulas. Palps are limbs that male spiders use to, among other things, transfer sperm while mating. Technically, palps are not penises but rather secondary sex organs. Satyrex ferox, whose legspan is around 5.5 inches (14 centimeters), has male palps up to 2 inches long (5 cm). For comparison, that's almost as long as its longest legs.
Since male spiders, unlike male humans, probably don't go around comparing their nether regions to each other, what's the point of adorning such lengthy junk?
For S. ferox specifically, 'we have tentatively suggested that the long palps might allow the male to keep a safer distance during mating and help him avoid being attacked and devoured by the highly aggressive female,' Alireza Zamani, lead author of the study and an arachnologist from the University of Turku, said in a Pensoft blog post (Pensoft published ZooKeys). Yes, you read that right.
View this post on Instagram'This species is highly defensive. At the slightest disturbance, it raises its front legs in a threat posture and produces a loud hissing sound by rubbing specialized hairs on the basal segments of the front legs against each other,' Zamani added. In fact, ferox means 'fierce.'
In other words, Zamani and colleagues suggest S. ferox may have evolved to have such long genitals because it allows them to have sex without getting eaten by their partner. Talk about a love bite.
In comparison, the other species' names are more boring. Researchers named S. speciosus for their beautiful colors and S. arabicus and S. somalicus for their regions of origin. According to the study, the new genus also includes a fifth Satyrex—a known species previously classified in the genus Monocentropus, now called S. longimanus.
'The much longer palps of S. longimanus and the four newly described species were among the primary characters that led us to establish a new genus for these spiders, rather than place them in Monocentropus,' Zamani concludes. 'So yes, at least in tarantula taxonomy, it seems that size really does matter.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
4 hours ago
- Medscape
Meta-Analysis Finds Biologic Switches Effective in Psoriasis
TOPLINE: Interclass biologic switching is effective and safe in patients with psoriasis, though switching from an anti-tumor necrosis factor (anti-TNF)-alpha to an anti-interleukin (IL)-17A treatment was associated with higher risk for adverse events (AEs), according to a meta-analysis. METHODOLOGY: To evaluate the safety and effectiveness of switching treatments after an initial biologic treatment fails, researchers conducted a meta-analysis of 24 randomized clinical trials published through January 25, 2025, which included 12,661 adults with psoriasis who switched from one biologic agent to another within the same class or in a different class. Eight switching categories were analyzed. The primary endpoint was the Psoriasis Area and Severity Index (PASI) 90 score, and secondary endpoints included safety. TAKEAWAY: PASI 90 improved significantly in patients after interclass biologic switching both at week 4 (11 studies; odds ratio [OR], 6.53; 95% CI, 2.58-16.51) and long term (OR, 28.61; 95% CI, 12.89-63.47). All switches were effective in the short term, whereas most switches achieved a PASI 90 response in the long term, except for switches from anti-IL-17A agents to anti-IL-17A/F agents. Long-term, marked improvements were observed when switching from anti-TNF-alpha agents to anti-IL-23p19 agents (OR, 23.72; 95% CI, 4.29-130.98) and from anti-IL-12/23p40 agents to anti-IL-23p19 agents (OR, 19.87; 95% CI, 10.40-37.94). No major safety differences were observed overall, except for increased serious adverse events (AEs) when switching from an anti-TNF-alpha agent to an anti-IL-17A agent (OR, 2.45; 95% CI, 1.25-4.83). Switching from anti-TNF-alpha agents to anti-IL-23p19, anti-IL-17A, or anti-IL-12/23p40 agents was associated with infection rates of 0.62%, 0.54%, and 0.39%, respectively. The highest risk for Candida infection (0.16%) was observed when switching from anti-TNF-alpha agents to anti-IL-17A/F agents. Switching to a different biologic class showed comparable effectiveness and safety with continuing the same agent, with regards to AEs. IN PRACTICE: This systematic review and meta-analysis found that 'interclass biologic switching was effective, and there were no safety differences for most patients,' the study authors wrote. 'Switching to anti-IL-23p19, anti-IL-17A, or anti-IL-12/23p40 agents from anti-TNF-alpha agents posed the greatest risk of infection,' they added, recommending 'vigilance for infections while switching to different biologics.' SOURCE: The study was led by Miao Zhang, MD, Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China, and was published online on August 6 in JAMA Dermatology. LIMITATIONS: Limitations included heterogeneity in study designs, potential differences between biologics and batch variability which could have affected effectiveness comparisons after switching, insufficient data for several comparisons. DISCLOSURES: The study was supported by the National Natural Science Foundation of China, the Key Discipline Construction Project of Shanghai's 3-Year Action Plan for Strengthening the Construction of Public Health System, Shanghai Oriental Talent Program for Top-notch Project, CACMS Innovation Fund, Shanghai Healthy Special Project, The Shanghai 2022 Science and Technology Innovation Action Plan Medical Innovation Research Special Project, the Clinical Research Plan of Shanghai Shenkang Hospital Development Center, the High-level Chinese Medicine Key Discipline Construction Project, Evidence-based dermatology base sponsored by State Administration of Traditional Chinese Medicine, and the Shanghai Hospital Development Center Foundation. The authors reported having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Medscape
7 hours ago
- Medscape
Even Low Lead Exposure Can Impair Academic Outcomes in Kids
TOPLINE: Every 1-unit increase in blood lead levels in early childhood — even when below the 'safe' threshold of 3.5 µg/dL — was associated with declines in math and reading scores from grades 2 through 11, similar to those seen at higher lead levels. METHODOLOGY: Researchers used the 2021 US CDC's revision of the blood lead reference value to ≥ 3.5 μg/dL. They analyzed data from birth certificates of children born in Iowa from 1989 to 2010, academic test scores from grades 2 through 11, and blood lead testing data from 1990 to 2017. The analysis included 305,256 children (mean age at lead testing, 1.9 years; 49% girls) and nearly 1.8 million math and reading scores to calculate the national percentile rank (NPR). Primary outcomes included NPR scores across grades 2 through 11, comparing children with blood lead levels < 3.5 μg/dL with those at or above this threshold. TAKEAWAY: Overall, 37.7% of children had lead levels < 3.5 μg/dL. Among children with blood lead levels < 3.5 μg/dL, a 1-unit increase was associated with lower NPR scores in math (-0.47; 95% CI, -0.65 to -0.30) and in reading (-0.38; 95% CI, -0.56 to -0.20). Similarly, for lead levels at ≥ 3.5 μg/dL, every 1-unit increase was linked to a significant decline in NPR scores for math and reading. The trend of declining scores with increasing lead levels was persistent across grades 2 through 11; only the declines in reading scores for grades 10 and 11 were not statistically significant. IN PRACTICE: 'The present work provides further evidence to support that there are no safe levels of lead and that there is a need to continue to reduce or eliminate lead exposure,' the authors of the study wrote. SOURCE: This study was led by George L. Wehby, MPH, PhD, of the Department of Health Management and Policy at the University of Iowa in Iowa City, Iowa. It was published online on May 28, 2025, in JAMA Network Open. LIMITATIONS: Several laboratories used the old 5 μg/dL cutoff to quantify high lead levels. Researchers lacked data on any lead-related interventions the children may have received. DISCLOSURES: Wehby reported receiving grants from the Gates Foundation during the conduct of this study. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Yahoo
8 hours ago
- Yahoo
Scientists say it may be possible to protect aging brains from Alzheimer's with an old remedy — lithium
In a major new finding almost a decade in the making, researchers at Harvard Medical School say they've found a key that may unlock many of the mysteries of Alzheimer's disease and brain aging — the humble metal lithium. Lithium is best known to medicine as a mood stabilizer given to people who have bipolar disorder and depression. It was approved by the US Food and Drug Administration in 1970, but it was used by doctors to treat mood disorders for nearly a century beforehand. Now, for the first time, researchers have shown that lithium is naturally present in the body in tiny amounts and that cells require it to function normally — much like vitamin C or iron. It also appears to play a critical role in maintaining brain health. In a series of experiments reported Wednesday in the journal Nature, researchers at Harvard and Rush universities found that depleting lithium in the diet of normal mice caused their brains to develop inflammation and changes associated with accelerated aging. In mice that were specially bred to develop the same kinds of brain changes as humans with Alzheimer's disease, a low-lithium diet revved the buildup of sticky proteins that form plaques and tangles in the brains that are hallmarks of the disease. It also sped up memory loss. Maintaining normal lithium levels in mice as they aged, however, protected them from brain changes associated with Alzheimer's. If further research supports the findings, it could open the door to new treatments and diagnostic tests for Alzheimer's, which affects an estimated 6.7 million older adults in the United States, according to the US Centers for Disease Control and Prevention. A unifying theory of Alzheimer's disease The research provides a unifying theory that helps explain so many of the puzzle pieces scientists have been trying to fit together for decades. 'It is a potential candidate for a common mechanism leading to the multisystem degeneration of the brain that precedes dementia,' said Dr. Bruce Yankner, a professor of genetics at Harvard Medical School, who led the study. 'It will take a lot more science to determine whether this is a common pathway… or one of several pathways,' to Alzheimer's, he added. 'The data are very intriguing.' In an editorial published in Nature, Dr. Ashley Bush, a neuroscientist who directs the Melbourne Dementia Research Center at the University of Melbourne in Australia, said the researchers 'present compelling evidence that lithium does in fact have a physiological role and that normal aging might impair the regulation of lithium levels in the brain.' He was not involved in the study. Close examination of human and animal brain tissues, along with genetic investigations in the study, found the mechanism that appears to be at play: Beta amyloid plaques — the sticky deposits that gum up the brains of Alzheimer's patients — bind to lithium and hold it, including the type that's normally present in the body, as well as the commonly prescribed form. This binding depletes lithium available for nearby cells, including important scavengers known as microglia. When the brain is healthy and functioning normally, microglia are waste managers, clearing away beta amyloid before it can accumulate and can cause harm. In the team's experiments, microglia from the brains of lithium-deficient mice showed a reduced ability to sweep away and break down beta amyloid. Yankner believes this creates a downward spiral. The accumulation of beta amyloid soaks up more and more lithium, further crippling the brain's ability to clear it away. He and his colleagues tested different lithium compounds and found one — lithium orotate — that doesn't bind to amyloid beta. When they gave lithium orotate to mice with signs of Alzheimer's in their brains, these changes reversed: Beta amyloid plaques and tangles of tau that were choking the memory centers of the brain were reduced. Mice treated with lithium were once again able to navigate mazes and learn to identify new objects, whereas those who got placebos showed no change in their memory and thinking deficits. Don't try this at home In its natural form, lithium is an element, a soft, silvery-white metal that readily combines with other elements to form compounds and salts. It's naturally present in the environment, including in food and water. Scientists have never fully known how it works to improve mood — only that it does. The original formula for 7Up soda included lithium — it was called 7Up Lithiated Lemon Soda — and touted as a hangover cure and mood lifter 'for hospital or home use.' Some hot springs known to contain mineral water brimming with lithium became sought out wellness destinations for their curative powers. Still, people who take prescription doses of lithium — which were much higher than the doses used in the new study — can sometimes develop thyroid or kidney toxicity. Tests of the mice given low doses of lithium orotate showed no signs of damage. That's encouraging, Yankner said, but it doesn't mean people should try to take lithium supplements on their own. 'A mouse is not a human. Nobody should take anything based just on mouse studies,' Yankner said. 'The lithium treatment data we have is in mice, and it needs to be replicated in humans. We need to find the right dose in humans,' he added. The normal amounts of lithium in our bodies, and the concentrations given to the mice, are small — about 1,000 times lower than doses given to treat bipolar disorder, Yankner notes. Yankner said he hoped toxicity trials of lithium salts would start soon. Neither he nor any of his co-authors have a financial interest in the outcome of the research, he said. The National Institutes of Health was the major funder of the study, along with grants from private foundations. 'NIH support was absolutely critical for this work,' Yankner said. Evidence builds for lithium's role in aging The new research corroborates earlier studies hinting that lithium might be important for Alzheimer's. A large Danish study published in 2017 found people with higher levels of lithium in their drinking water were less likely to be diagnosed with dementia compared with those whose tap water contained naturally lower lithium levels. Another large study published in 2022 from the United Kingdom found that people prescribed lithium were about half as likely has those in a control group to be diagnosed with Alzheimer's, suggesting a protective effect of the drug. But lithium's use in psychiatry caused it to become type cast as therapeutic, Yankner said. No one realized it might be important to the body's normal physiology. That happened in part because the amounts of lithium that typically circulate in the body are so small, they couldn't be quantified until recently. Yankner and his team had to adapt new technology to measure it. In the first stage of the research, the scientists tested the brain tissue and blood of older patients collected by the brain bank at Rush University for trace levels of 27 metals. Some of the patients had no history of memory trouble, while others had early memory decline and pronounced Alzheimer's. While there was no change in the levels of most metals they measured, lithium was an exception. Lithium levels were consistently lower in patients with mild cognitive impairment or Alzheimer's compared to those with normal brain function. The brains of patients Alzheimer's disease also showed increased levels of zinc and decreased levels of copper, something scientists had observed before. Consistently finding lower lithium levels in the brains of people with memory loss amounted to a smoking gun, Yankner said. 'At first, frankly, we were skeptical of the result because it wasn't expected,' said Yankner. But it held up even when they checked samples from other brain banks at Massachusetts General Hospital, Duke and Washington universities. 'We wanted to know whether this drop in lithium was biologically meaningful, so we devised an experimental protocol where we could take lithium selectively out of the diet of mice and see what happens,' Yankner said. When they fed the mice a low-lithium diet, simply dropping their natural levels by 50%, their brains rapidly developed features of Alzheimer's. 'The neurons started to degenerate. The immune cells in the brain went wild in terms of increased inflammation and worse maintenance function of the neurons around them, and it looked more like an advanced Alzheimer patient,' Yankner said. The team also found the gene expression profiles of lithium-deficient mice and people who had Alzheimer's disease looked very similar. The researchers then started to look at how this drop in lithium might occur. Yankner said in the earliest stages there's a decrease in the uptake of lithium in the brain from the blood. They don't yet know exactly how or why it happens, but it's likely to be from a variety of things including reduced dietary intake, as well as genetic and environmental factors. The major source of lithium for most people is their diet. Some of the foods that have the most lithium are leafy green vegetables, nuts, legumes and some spices like turmeric and cumin. Some mineral waters are also rich sources. In other words, Yankner said, a lot of the foods that have already proven to be healthy and reduce a person's risk of dementia may be beneficial because of their lithium content. 'You know, oftentimes one finds in science that things may have an effect, and you think you know exactly why, but then subsequently turn out to be completely wrong about why,' he said. Solve the daily Crossword
